| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.04 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |